ENDORSE: a prognostic model for endocrine therapy in estrogen‐receptor‐positive breast cancers
Abstract Advanced and metastatic estrogen receptor‐positive (ER+) breast cancers are often endocrine resistant. However, endocrine therapy remains the primary treatment for all advanced ER+ breast cancers. Treatment options that may benefit resistant cancers, such as add‐on drugs that target resista...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer Nature
2022-06-01
|
Series: | Molecular Systems Biology |
Subjects: | |
Online Access: | https://doi.org/10.15252/msb.202110558 |